Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.
Funding Agency: NIH
Deadline: September 25, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-374.html
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)
The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that harnesses the wealth of advances in the fields of genomics and other omics (e.g., metabolomics, microbiomics, proteomics, transcriptomics, epigenomics, etc.) to incorporate these advances into translatable, personalized biobehavioral interventions for improved health outcomes.
Funding Agency: NIH
Deadline: January 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-377.html
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)
This UE5 funding opportunity announcement (FOA) is for a part of the NCIs Informatics Technology for Cancer Research (ITCR) program (https://itcr.cancer.gov/), and establishes an ITCR Education Center to provide education resources that will enhance the use and usability of the informatics tools and resources developed and supported by the ITCR program through education of both the cancer research community as well as informatics tool developers. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development The proposed Center will provide focused education courses in each of the following two areas (1) thematic topics in cancer informatics and (2) informatics tool usability and user support . The courses supporting education in thematic topics in cancer informatics should cover the variety of domains represented by the ITCR program and incorporate ITCR tools as exemplars for applying informatics methods, including, as appropriate, hands-on training on the associated tools and analysis workflows for participants. The courses in informatics tool usability and user support should focus on activities that target the needs of currently funded ITCR investigators, and provide guidance in enhancing the usability and user support of their tools.
Funding Agency: NIH
Deadline: July 31, 2020
Amount: $750,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-042.html
Mobile Health: Technology and Outcomes in Low Middle Income Countryies (R21/R33 – Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution.
Funding Agency: NIH
Deadline: December 3, 2020
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-376.html
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31)
This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Funding Agency: NIH
Deadline: September 7, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-378.html
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)
This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Funding Agency: NIH
Deadline: September 7, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-379.html
Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for infrastructure support to advance the development of efficacy and/or effectiveness research on recovery support services for those who were or who are being maintained on medications for the treatment of opioid use disorder. The infrastructure support will facilitate multi-stakeholder (e.g. researchers and students, payors, providers, individuals in recovery) research networks through meetings, conferences, small-scale pilots, data development work, short-term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and to build resources for advancing recovery support services research. Network applications are to support research related to the following priority recovery support services (1) peer-based recovery support, (2) recovery community centers, (3) active recovery communities, (4) recovery residences, (5) education-based recovery support services, and (6) continuing care models, or others proposed by applicants.
Funding Agency: NIH
Deadline: November 19, 2019
Amount: $400,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-014.html
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Funding Agency: NIH
Deadline: January 15, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-026.html
Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed)
The Funding Opportunity Announcement (FOA) invites applications seeking to examine the outcomes of care for persons with Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) through identifying home and community-based services (HCBS) used, as well as barriers to accessing these types of care, and unmet needs of persons with AD/ADRD concerning care and services.
Funding Agency: NIH
Deadline: February 3, 2020
Amount: $400,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-037.html
Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites applications to examine the outcomes of care for persons with Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) by identifying home- and community-based services (HCBS) used, as well as barriers to accessing these types of care and unmet needs of persons with AD/ADRD concerning care and services in these settings. This R21 FOA is particularly seeking applications that will develop new measurement instruments in this field and ways to improve data quality and access.
Funding Agency: NIH
Deadline: February 3, 2020
Amount: $250,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-038.html
Pregnancy as a Vulnerable Time Period for Women’s Health (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate multidisciplinary research projects studying the effects of environmental chemicals on maternal physiology, and endocrine and metabolic functions during and shortly after pregnancy, as well as potential long-term maternal health effects caused by environmental exposures.
Funding Agency: NIH
Deadline: December 6, 2019
Amount: $300,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-20-003.html
Patient Activation for Self-Management of Chronic Conditions (R21 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
Funding Agency: NIH
Deadline: May 7, 2023
Amount: $200,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-382.html
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that The overarching goal of this NHGRI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in genomics. This funding opportunity announcement seeks to expose underrepresented students at the undergraduate, post-baccalaureate and graduate levels to the foundational sciences relevant to genomics to enable them to pursue careers that span all areas of interest to NHGRI – genome sciences, genomic medicine and genomics and society. For the purposes of this FOA, the term genomics encompasses issues and activities in these three areas of genomic research.
Funding Agency: NIH
Deadline: September 25, 2022
Amount: $300,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-380.html
Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/T33 Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to encourage the use of a phased research approach to generate information needed to develop interventions to reduce long-term effects of in utero exposure to antiretroviral therapy (ART) and/or HIV on health outcomes. This FOA will support two-phased research applications to (1) demonstrate the capacity to enroll sufficient numbers of HIV-exposed uninfected (HEU) infants, children, adolescents, and/or young adults in the United States and/or international settings with high HIV burden, and then, to (2) utilize the established cohort with innovative epidemiological approaches to conduct research.
Funding Agency: NIH
Deadline: December 2, 2019
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-008.html
Patient Activation for Self-Management of Chronic Conditions (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
Funding Agency: NIH
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-381.html
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
This funding opportunity announcement (FOA) is a continuation of Cancer Intervention and Surveillance Modeling Network (CISNET – https://cisnet.cancer.gov) program. This FOA invites applications for collaborative research projects using simulation and other modeling techniques for specific cancer types (see below). The proposed research is expected to generate sophisticated, evidence-based decision tools that could inform international/national/regional/local decisions on the most efficient utilization of existing and emerging technologies and strategies for the control of cancer
Funding Agency: NIH
Deadline: December 10, 2019
Amount: $1,330,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-054.html
Innovative Programs to Enhance Research Training (IPERT) (R25 – Independent Clinical Trial Not Allowed)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce to meet the nations biomedical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on skills development, mentoring, and outreach to equip a diverse cohort of participants with the technical, operational, and professional skills required for careers in the biomedical research workforce. Funded programs are expected to have robust evaluation, dissemination, and sustainability plans.
Funding Agency: NIH
Deadline: October 15, 2021
Amount: $500,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-383.html
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)
This funding opportunity announcement (FOA) solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider this FOAs companion for basic experimental studies with humans.
Funding Agency: NIH
Deadline: March 17, 2021
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-373.html
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)
This funding opportunity announcement (FOA) solicits research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena related to social connectedness and isolatedness. NIH considers such studies as prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of a clinical trials (see, e.g., NOT-OD-19-024)
Funding Agency: NIH
Deadline: March 17, 2021
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-384.html
NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) requests applications for the Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program. The HCCC is expected to work collaboratively with 4-5 Cooperative Centers of Excellence in Hematology (CCEHs) as part of the NIDDK Hematology Centers Program and serve as a national resource for the larger nonmalignant hematology research community. The HCCC will provide central administrative and communications support for the NIDDK Hematology Centers Program and operate a Pilot and Feasibility Program, supporting pilot research studies that will lead to larger research projects. All activities within the Program are expected to address the overall goal of supporting the national multidisciplinary research effort to combat nonmalignant hematologic diseases and/or to study normal hematopoiesis.
Funding Agency: NIH
Deadline: November 21, 2019
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-013.html